Trial Profile
A 24-MONTH, RANDOMIZED, DOUBLE-BLIND, TWO PERIOD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF ETANERCEPT AND METHOTREXATE AND METHOTREXATE ALONE IN SUBJECTS WITH ACTIVE EARLY RHEUMATOID ARTHRITIS: COMBINATION OF METHOTREXATE AND ETANERCEPT IN ACTIVE EARLY RHEUMATOID ARTHRITIS (COMET)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2023
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms COMET
- Sponsors Wyeth
- 13 Jun 2015 Subanalysis of results at 104 weeks presented at the 16th Annual Congress of the European League Against Rheumatism.
- 02 Nov 2012 Planned number of patients changed from 540 to 580.
- 09 Nov 2011 Results on optimal dose range of methotrexate presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.